Quality of life studies and genito-urinary tumors

Annals of Oncology

Volumn 12, Issue SUPPL. 3, 2001, Pages

  Bertetto, O ^a   Bracarda, S ^b   Tamburini, M ^c   Cortesi, E ^d  

^a MOLINETTE HOSPITAL   (Italy)

^b Medical Oncology Division   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Genito urinary tumors; Quality of life

Indexed keywords

ANTIANDROGEN; ANTINEOPLASTIC AGENT; ESTRAMUSTINE; FLUTAMIDE; GONADORELIN DERIVATIVE; KETOCONAZOLE; MITOXANTRONE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; ASTHENIA; BEHAVIOR; BLADDER CANCER; BLADDER SURGERY; BODY IMAGE; BRACHYTHERAPY; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; CLINICAL TRIAL; CONSERVATIVE TREATMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; MALE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; ORCHIECTOMY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; TESTIS CANCER; TREATMENT OUTCOME; UROGENITAL TRACT CANCER; UROLOGIC SURGERY;

EID: 0035667998     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/12.suppl_3.S43     Document Type: Article

References (36)

1. Changes in prostate cancer incidence and treatment in the USA
2. An analysis of watchful waiting for clinically localized prostate cancer
3. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [see comments]
4. Retrospective comparison of radical retropubic prostatectomy and 125iodine brachytherapy for localized prostate cancer
5. External beam radiotherapy vs. radical prostatectomy for clinical stage T1-2 prostate cancer: Therapeutic implications of stratification by pre-treatment PSA levels and biopsy Gleason scores [see comments]
6. Quality of life and treatment outcomes: Prostate carcinoma patient's perspectives after prostatectomy or radiation therapy
7. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy
8. Changes in quality of life following treatment for early prostate cancer
9. A controlled trial of leuprolide with and without flutamide in prostatic carcinoma
10. The quality of life of patients with newly diagnosed M1 prostate cancer: Experience with EORTC Clinical Trial 30853
11. Bilateral orchiectomy with or without flutamide for metastatic prostate cancer (NCI-INT-0105 SWOG/ECOG)
12. Maximum androgen blockade in advanced prostate cancer: An overview of the randomised trials
13. Quality of life in advanced prostate cancer: Results of a randomized therapeutic study
14. Intermittent androgen suppression in the treatment of prostate cancer: A preliminary report
15. Quality of life and treatment of hormone resistant metastatic prostatic cancer
16. Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: A Canadian randomized trial with palliative end points
17. Gli endpoint degli studi clinici in oncologia
18. Recombinant human interleukin-2, recombinant human interferon alfa-2, or both in metastatic renal cell carcinoma
19. Health related quality of life outcomes in patients treated for metastatic kidney cancer: A pilot study
20. Interleukin-2 based immunotherapy for the treatment of metastatic renal cell carcinoma: An analysis of 203 consecutively treated patients
21. Invasive bladder cancer: Treatment strategies using transurethral surgery, chemotherapy and radiation therapy with selection for bladder conservation
22. Invasive bladder cancer: Our experience with bladder sparing approach
23. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy
24. Quality of life after radical cystectomy for bladder cancer in patients with an ileal conduit, or cutaneous or urethral kock pouch
25. Assessment of quality of life after cystectomy or conservative therapy for patients with infiltrating bladder carcinoma
26. Psychosocial aspects in long term survivors of testicular cancer
27. Late toxicity following curative treatment of testicular cancer
28. Health related quality of life in patients treated for testicular cancer
29. Evaluation of sexual life after orchidectomy followed by radiotherapy for early stage seminoma of the testis
30. Psychosocial adjustment after testicular cancer treatment
31. The European Organization for Research and Treatment of Cancer QLQ-C30: A quality of life instrument for use in international clinical trials in oncology
32. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure
33. Measuring quality of life in men with prostate cancer using the functional assessment of cancer therapy-prostate instrument
34. The UCLA prostate cancer index: Development, reliability, and validity of a health-related quality of life measure
35. Convergent, discriminative, and predictive validity of the prostate cancer specific quality of life instrument (PROSQUOLI) Assessment and comparison with analogous scales from the EORTC QLQ-C30 and a trial-specific module
36. Responsiveness to change in health-related quality of life in a randomized clinical trial: A comparison of the Prostate Cancer Specific Quality of Life Instrument (PROSQOLI) with analogous scales from the specific module. European Organization for Research and Treatment of Cancer